BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 22065586)

  • 1. Oncogenic Ras and B-Raf proteins positively regulate death receptor 5 expression through co-activation of ERK and JNK signaling.
    Oh YT; Yue P; Zhou W; Balko JM; Black EP; Owonikoko TK; Khuri FR; Sun SY
    J Biol Chem; 2012 Jan; 287(1):257-267. PubMed ID: 22065586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paradoxical activation of MEK/ERK signaling induced by B-Raf inhibition enhances DR5 expression and DR5 activation-induced apoptosis in Ras-mutant cancer cells.
    Oh YT; Deng J; Yue P; Sun SY
    Sci Rep; 2016 May; 6():26803. PubMed ID: 27222248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ERK/ribosomal S6 kinase (RSK) signaling positively regulates death receptor 5 expression through co-activation of CHOP and Elk1.
    Oh YT; Liu X; Yue P; Kang S; Chen J; Taunton J; Khuri FR; Sun SY
    J Biol Chem; 2010 Dec; 285(53):41310-9. PubMed ID: 21044953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of B-Raf/MEK/ERK signaling suppresses DR5 expression and impairs response of cancer cells to DR5-mediated apoptosis and T cell-induced killing.
    Oh YT; Deng J; Yue P; Owonikoko TK; Khuri FR; Sun SY
    Oncogene; 2016 Jan; 35(4):459-67. PubMed ID: 25867065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kaempferol Sensitizes Human Ovarian Cancer Cells-OVCAR-3 and SKOV-3 to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)-Induced Apoptosis via JNK/ERK-CHOP Pathway and Up-Regulation of Death Receptors 4 and 5.
    Zhao Y; Tian B; Wang Y; Ding H
    Med Sci Monit; 2017 Oct; 23():5096-5105. PubMed ID: 29070784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer ETS rearrangements switch a cell migration gene expression program from RAS/ERK to PI3K/AKT regulation.
    Selvaraj N; Budka JA; Ferris MW; Jerde TJ; Hollenhorst PC
    Mol Cancer; 2014 Mar; 13():61. PubMed ID: 24642271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ras-mutant cancer cells display B-Raf binding to Ras that activates extracellular signal-regulated kinase and is inhibited by protein kinase A phosphorylation.
    Li Y; Takahashi M; Stork PJS
    J Biol Chem; 2013 Sep; 288(38):27646-27657. PubMed ID: 23893412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of ERK1/2-mediated ELK1/CHOP/DR5 pathway in 6-(methylsulfinyl)hexyl isothiocyanate-induced apoptosis of colorectal cancer cells.
    Yano S; Wu S; Sakao K; Hou DX
    Biosci Biotechnol Biochem; 2019 May; 83(5):960-969. PubMed ID: 30730256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Death Receptor 4 Is Positively Regulated by MEK/ERK/AP-1 Signaling and Suppressed upon MEK Inhibition.
    Yao W; Oh YT; Deng J; Yue P; Deng L; Huang H; Zhou W; Sun SY
    J Biol Chem; 2016 Oct; 291(41):21694-21702. PubMed ID: 27576686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simvastatin inhibition of mevalonate pathway induces apoptosis in human breast cancer cells via activation of JNK/CHOP/DR5 signaling pathway.
    Gopalan A; Yu W; Sanders BG; Kline K
    Cancer Lett; 2013 Feb; 329(1):9-16. PubMed ID: 22960596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of endoplasmic reticulum stress in alpha-TEA mediated TRAIL/DR5 death receptor dependent apoptosis.
    Tiwary R; Yu W; Li J; Park SK; Sanders BG; Kline K
    PLoS One; 2010 Jul; 5(7):e11865. PubMed ID: 20686688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The farnesyltransferase inhibitor lonafarnib induces CCAAT/enhancer-binding protein homologous protein-dependent expression of death receptor 5, leading to induction of apoptosis in human cancer cells.
    Sun SY; Liu X; Zou W; Yue P; Marcus AI; Khuri FR
    J Biol Chem; 2007 Jun; 282(26):18800-9. PubMed ID: 17493934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bile acid regulates MUC2 transcription in colon cancer cells via positive EGFR/PKC/Ras/ERK/CREB, PI3K/Akt/IkappaB/NF-kappaB and p38/MSK1/CREB pathways and negative JNK/c-Jun/AP-1 pathway.
    Lee HY; Crawley S; Hokari R; Kwon S; Kim YS
    Int J Oncol; 2010 Apr; 36(4):941-53. PubMed ID: 20198339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PKCĪ“ regulates death receptor 5 expression induced by PS-341 through ATF4-ATF3/CHOP axis in human lung cancer cells.
    Xu L; Su L; Liu X
    Mol Cancer Ther; 2012 Oct; 11(10):2174-82. PubMed ID: 22848091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRAIL receptor upregulation and the implication of KRAS/BRAF mutations in human colon cancer tumors.
    Oikonomou E; Kosmidou V; Katseli A; Kothonidis K; Mourtzoukou D; Kontogeorgos G; Andera L; Zografos G; Pintzas A
    Int J Cancer; 2009 Nov; 125(9):2127-35. PubMed ID: 19637313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The heme oxygenase-1 protein is overexpressed in human renal cancer cells following activation of the Ras-Raf-ERK pathway and mediates anti-apoptotic signal.
    Banerjee P; Basu A; Datta D; Gasser M; Waaga-Gasser AM; Pal S
    J Biol Chem; 2011 Sep; 286(38):33580-90. PubMed ID: 21808062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
    McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
    Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of ATF3 in synergistic cancer cell killing by a combination of HDAC inhibitors and agonistic anti-DR5 antibody through ER stress in human colon cancer cells.
    Liu J; Edagawa M; Goshima H; Inoue M; Yagita H; Liu Z; Kitajima S
    Biochem Biophys Res Commun; 2014 Mar; 445(2):320-6. PubMed ID: 24530917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Butein sensitizes human hepatoma cells to TRAIL-induced apoptosis via extracellular signal-regulated kinase/Sp1-dependent DR5 upregulation and NF-kappaB inactivation.
    Moon DO; Kim MO; Choi YH; Kim GY
    Mol Cancer Ther; 2010 Jun; 9(6):1583-95. PubMed ID: 20515942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-Raf inhibits MAPK activation and transformation by B-Raf(V600E).
    Karreth FA; DeNicola GM; Winter SP; Tuveson DA
    Mol Cell; 2009 Nov; 36(3):477-86. PubMed ID: 19917255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.